latest newsRead more...
28
Jun 2017NeuroVive and Yungjin Pharm Start Clinical Development in Genetic Mitochondrial Disease
NeuroVive Pharmaceutical AB and Yungjin Pharm Corporation Ltd announced that the clinical phase I study of KL has started in Korea and that the first healthy volunteer has been enrolled The study is a doubleblind placebocontrolled singledose doseescalation phase I clinical study to investigate the…
28
Jun 2017Oramed Granted Japanese Patent for Combination Insulin and GLP-1 Analog Capsule
Oramed Pharmaceuticals Inc a clinicalstage pharmaceutical company focused on the development of oral drug delivery systems announced today that the Japanese Intellectual Property Office has publicized its intent to grant Oramed a patent titled Methods and Compositions for Treating Diabetes The patent covers Orameds invention…
27
Jun 2017Breckenridge Pharmaceutical, Inc. Announces Final ANDA Approval for Azacitidine for Injection (Vidaza®)
Breckenridge Pharmaceutical Inc announced that FDA has granted final approval of its ANDA Azacitidine for Injection mg per vial SingleDose Vial a generic version of Vidaza by Celgene Corporation Breckenridge submitted the ANDA with its development and manufacturing partner Natco Pharma Limited Breckenridge and Natco…
press releasesRead more...
28
Jun 2017Mitoconix Bio Raises $20 Million in Series A Funding to Develop Neurodegenerative Disease Therapies
Mitoconix Bio Ltd a biopharmaceutical company focused on therapies for neurological diseases announced today that it has secured a million round of Series A funding The round was led by…
28
Jun 2017Evotec Expands iPSC Drug Discovery Leadership Through Strategic Collaboration with Censo Biotechnologies
Evotec AG announced a collaboration with Censo Biotechnologies Ltd Censo to source and provide patientderived induced pluripotent stem cells iPSC to support Evotecs broad iPSC platform Censo will provide its…
28
Jun 2017Canada’s Veterans Transition Network Helping Ukrainian Charity Develop Mental-Health Programs for Former Troops in Strife-Torn European Nation
VANCOUVER British Columbia June GLOBE NEWSWIRE Veterans Transition Network VTN a vitally important charity relied on by many former Canadian military servicemen and servicewomen for mental healthcare today announced that…
EventsRead more...
03-05
Jul 201716th Annual Medicinal & Pharmaceutical Sciences Congress
Conferenceseries Ltd
Kuala Lumpur
03-05
Jul 2017International Conference on Medical and Clinical Microbiology
Conference Series LLC
Bangkok
TOP ARTICLES
-
1
Nanotechnology-based Inhalation Treatment for Lung Cancer
The lungs are the primary organ of the respiratory system The respiratory system works with the circulatory system to deliver oxygen from the lungs to the cells..
-
2
Improving Biopharma Productivity through Optimal Bioreactor Operation
Generating global revenue of US billion biopharmaceuticals account for one fifth of pharmaceutical market The revenue grows at per cent annually which is doubl..
-
3
Parenteral Preparations
INTRODUCTION Parenteral preparations are defined as solutions suspensionsemulsions for injection or infusion powders for injection or infusion gels for injecti..
-
4
The Impact of Materials Handling on Facility Design and Operation
Materials handling a fundamental decision All too often the design of pharmaceutical OSD production facilities fails to recognise the impact on and the oppo..
-
5
Untapped Opportunities in Southeast Asia
Southeast Asia is a growing pharmaceutical market with an increase in clinical trials in recent years With a population of about million and a total area of m..
-
6
When Orphan Drugs Make All the Difference
Orphan drugs those medications that are typically produced in small quantities for limited patient populations are growing in importance worldwide Once largely ..
Knowledge Bank
-
Interviews
Datwyler Pharma Packaging
Senior Manager Global Scientific Affairs
Renaud Janssen PhD is the Senior Manager of Global Scientific Affairs at Datwyler Pharma Packaging He frequently presents on international conferences on subjects related to elastomeric and aluminiumplastic closures for pharmaceutical applications Re..
-
Articles
The European Lead Factory
In drug discovery the search for new chemical equity to be developed into valuable preclinical and clinical candidates is very time and costintensive This is a particular difficulty for academics or small and medium enterprises SMEs who are likely to have limited resources Additionally small companies are often created around a single compound or…
-
Research Insights
Clonal Evolutionary Analysis during HER2 Blockade in HER2-Positive Inflammatory Breast Cancer: A Phase II Open-Label Clinical Trial of Afatinib +/- Vinorelbine
Abstract Background Inflammatory breast cancer IBC is a rare aggressive form of breast cancer associated with HER amplification with high risk of metastasis and an estimated median survival of y We performed an openlabel singlearm phase II clinical trial ClinicalTrialsgov NCT to investigate the efficacy and safety of afatinib an irreversible ErbB family inhibitor alone and in combination with vinorelbine…
-
Case Studies
Rapid, Comprehensive, And Aff Ordable Mycobacterial Diagnosis With Whole-genome Sequencing: A Prospective Case Study
Abstract Background Slow and cumbersome laboratory diagnostics for Mycobacterium tuberculosis complex MTBC risk delayed treatment and poor patient outcomes Wholegenome sequencing WGS could potentially provide a rapid and comprehensive diagnostic solution In this prospective study we compare realtime WGS with routine MTBC diagnostic workflows Methods We compared…
-
Techno Trends
Evotec and Eternygen to Develop Novel Metabolic Disease Therapy
Evotec and Eternygen announced a drug discovery collaboration to develop novel metabolic disease therapy The two companies will develop novel small molecule inhibitors against an Eternygen target to treat metabolic disease using Evotecs technology platform and broad expertise in drug discovery and preclinical development Eternygen is working on the sodium coupled citrate transporter NaCT a novel target which is a…
-
White Papers
Launching Global Clinical Trials—best Practices For Efficient And Cost-effective Translations: A Lionsbridge White Paper
Summary The target market for conducting global clinical trials has changed significantly moving beyond pharmaceutical early adopters to the mainstream marketplace This shift has placed a heightened focus on the language challenges and complexity of running a global clinical trial More and more companies are moving toward ascending regions such as India and China to…
-
Industry Reports
Sanochemia Pharmazeutika AG (SAC) - Financial and Strategic SWOT Analysis Review
Sanochemia Pharmazeutika AG Sanochemia is a specialty pharmaceutical company that develops and manufactures of innovative drugs and diagnostics in selected indication areas such as neurodegeneration pain and cancer as well as diagnostic products based on contrast media The companys product portfolio includes radiological products including an array of xray imaging…
Advisory Board
Editorial Section
-
Strategy
Failing Data Integrity Audit is not an Option
The timetomarket of blooming Asian pharmaceutical companies especially from India and China are being slowed by the increasing concerns of global and local regulators over data integrity How can they meet regulators audit expectation on data integrity and provide assurance…
-
Research development
Reviving Pharma R&D Productivity with New Modalities
The pharmaceutical industry is facing a decline in RD productivity However genomics biomarkers and access to human tissue samples are offering a range of well validated but challenging biological targets To seize the opportunity leveraging New Modalities and abolishing silos…
-
Clinical Trails
Patient Recruitment
To address the challenges faced in patient recruitment and retention in clinical trials innovative technologies are being utilised in AsiaPacific as well as other regions to optimise the processes involved From patient matching to improving the consent process technology has…
-
Manufacturing
Added Costs for Added Protections
The Impact of Implementing Safety Features in Pharmaceutical Packaging and Labelling Serialization Unique Device Identification UDI and aggregation catalyse a paradigm shift for the entire industry and are already impacting the pharmaceutical supply chain In…
-
Information Technology
Electronic FDA Submissions
If your time to you is worth savin then you better start swimmin or youll sink like a stone for the times they are a changin Bob Dylan
-
Expert Talk
The Asian Healthcare Market
The Asian market is growing rapidly and along with this expansion comes the issue of drug counterfeiting Bernd offers his insight into the key trends affecting this market and what regulatory authorities are expecting manufacturers…